Brexpiprazole oral fast dissolving film (Heze Pharma)

布瑞哌唑口溶膜（和泽医药）

Report date: 2026/05/12 20:00:17

Base Information

Drug NameBrexpiprazole oral fast dissolving film (Heze Pharma)
Drug Alias Namebrexpiprazol布瑞哌唑brexpiprazole依匹哌唑brexpiprazolum +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor partial agonistsSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor partial agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesHangzhou Heze Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Heze Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A